These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25510697)

  • 1. Serum microRNAs in clear cell carcinoma of the ovary.
    Chao A; Lai CH; Chen HC; Lin CY; Tsai CL; Tang YH; Huang HJ; Lin CT; Chen MY; Huang KG; Chou HH; Chang TC; Chen SJ; Wang TH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):536-41. PubMed ID: 25510697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary analysis and screening of microRNAs in gastric cancer side population cells.
    Zhang HH; Gu GL; Zhang XY; Li FZ; Ding L; Fan Q; Wu R; Shi W; Wang XY; Chen L; Wei XM; Yuan XY
    World J Gastroenterol; 2015 Mar; 21(12):3519-26. PubMed ID: 25834316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
    Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
    Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
    Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
    Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.
    Hauser S; Wulfken LM; Holdenrieder S; Moritz R; Ohlmann CH; Jung V; Becker F; Herrmann E; Walgenbach-Brünagel G; von Ruecker A; Müller SC; Ellinger J
    Cancer Epidemiol; 2012 Aug; 36(4):391-4. PubMed ID: 22542158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA portraits in human vulvar carcinoma.
    de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes virus microRNA expression and significance in serous ovarian cancer.
    Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
    PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
    Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Ruan L; Xie Y; Liu F; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.
    Iwamoto H; Kanda Y; Sejima T; Osaki M; Okada F; Takenaka A
    Int J Oncol; 2014 Jan; 44(1):53-8. PubMed ID: 24212760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.